Hemato – Oncology Testing Market Worth USD 4.0 Billion : Increasing Incidence Of Hematologic Cancer
Major Growth Drivers: Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for developing new assays. On the other hand, Uncertain reimbursement scenario in different regions is expected to restrain the growth …